Nasdaq:US$16.11 (+0.00) | HKEX:HK$25.40 (-0.16) | AIM:£2.39 (+0.02)
Search Result
Previous Article   |   Next Article
Scientific Publications | 4 Jun 2021

ASCO 2021: A Multicenter Open-Label Phase 1 Study Evaluating the Safety and Tolerability of HMPL-306 in Patients with Locally Advanced or Metastatic Solid Tumors with IDH Mutations